U.S. FOOD & DRUG ADMINISTRATION (FDA) OFFICE OF INSPECTIONS AND INVESTIGATIONS (OII) BIOMANUFACTURING PRINCIPLES AND PROCESSES TRAINING SERIES
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The U.S. Food and Drug Administration (FDA), Office of Inspections and Investigations, is conducting market research via a Sources Sought Notice to identify capable vendors for a Biomanufacturing Principles and Processes Training series. The objective is to establish a stand-alone contract to deliver an enhanced four-course training curriculum for FDA investigators, focusing on biological therapeutic drug production, facility equipment design, analytical testing, and emerging technologies. This training is designed to ensure investigators can effectively monitor compliance with good manufacturing practices (GMP) regulations. The delivery model is blended, utilizing asynchronous web-based learning via the BTEC Shorts platform, synchronous webinars, classroom instruction, and hands-on laboratory training at the contractor's facilities. The anticipated period of performance runs from March 2027 through March 2032, consisting of a base year and four option years, with a potential six-month extension through September 2032. Key milestones include finalizing the first course within six months of award, making the full curriculum available by the end of the base year, and ensuring six separate cohorts complete the program by the end of the fourth option year. All deliverables must be Section 508 compliant and meet WCAG 2.0 A and AA standards. Interested parties must submit a completed Vendor Feedback Form, a capability statement, and any comments on the draft Statement of Work to the contracting officer by December 1, 2026.
General Info
Place of Performance
Silver Spring, MD, USASet-Aside
Documents
2Read all 2 documents
Due in 379 daysEvery page of every file, in your free workspace.
Read the documentsAI Contract Breakdown
Uniform Contract FormatSign up to view the full breakdown with detailed analysis of each section.
View Full BreakdownEverything you need to bid on this one
Open the full contract in your free workspace.
- 2 solicitation documentsRead every page
- AI contract breakdown12 sections, Uniform Contract Format
- Buyer contactEmail and phone
Ask CLEATUS
I've read this contract. Ask me anything.
Timeline
Response Deadline
Organization & Contact Information
Full Description
FOOD AND DRUG ADMINISTRATION (FDA)
OFFICE OF INSPECTIONS AND INVESTIGATIONS (OII)
BIOMANUFACTURING PRINCIPLES AND PROCESSES TRAINING SERIES
SOURCES SOUGHT NOTICE (SSN)
Description
The U.S. Food and Drug Administration's (FDA), Office of Acquisitions and Grants Services (OAGS), is conducting market research for obtaining Biomanufacturing Principles and Processes Training services.
THIS IS A SOURCES SOUGHT NOTICE (SSN) ONLY. This SSN is being issued in accordance with Federal Acquisition Regulation (FAR) Part 10, Market Research. It is for information, planning and market research purposes only and is not to be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. The Government reserves the right to contact any of the respondents after the submission deadline if additional information is required.
The purpose of this SSN is to identify and gain knowledge of potential business sources and small business sources that are capable of providing the full range of services described in this SSN and the attached Draft Statement of Work (SOW). Responses to this SSN will be utilized for a potential solicitation for an anticipated stand-alone contract for the Biomanufacturing Principles and Processes Training Program. The anticipated period of performance for this contract is March 2027 through March 2032 (base year, plus four (4) option years), with a potential 6-month extension of services pursuant to FAR 52.217-8, for a total potential period of performance through September 2032.
Requested Information
Interested parties are highly encouraged to respond to this SSN by providing the following information in their response:
- Completed Vendor Feedback Form – See attached Vendor Feedback Form
- If applicable, tracked changes/comments on draft SOW in MS Word format – See attached Draft SOW
- Capability Statement
Responses shall be submitted via email with the subject line "Sources Sought Notice - FDA SSN: OII-2027-133938” to the Contracting Officer, Nicholas Bisher (Sign up to see this detail), no later than 12:00pm (Eastern) on December 1, 2026.
Attachments
- Vendor Feedback Form
- Draft Statement of Work
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
